Home
GSC Advanced Research and Reviews
Peer-reviewed | Multidisciplinary Journal | Impact factor 8.3 | ISSN: 2582-4597 | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Breast lumps: Types, biomarkers and prognosis

Breadcrumb

  • Home
  • Breast Lumps: Types, Biomarkers and Prognosis
  • Breast lumps: Types, biomarkers and prognosis

Ahmed F. Hameed 1, Khalida I. Noel 1, * and Israa S. Ajeel 2

1 Department of Human Anatomy, College of Medicine, Mustansiriyah University, Baghdad, Iraq.
2 FICMS, Family Medicine, Ministry of Health/Al-Kadhimiya Directorate for Primary Health Care, Baghdad, Iraq.
 
Research Article
GSC Advanced Research and Reviews, 2022, 12(01), 126–134.
Article DOI: 10.30574/gscarr.2022.12.1.0199
DOI url: https://doi.org/10.30574/gscarr.2022.12.1.0199
Received on 22 June 2022; revised on 26 July 2022; accepted on 28 July 2022
 
Introduction: The breast is a dynamic organ in the female and the symptoms related to it considered a major cause enrolled the women to get medical intension, a complete physical, radiological, and cytological examination should be accomplished until the symptoms resolved or benign\ malignant condition established, there were many types of benign tumor in the breast: solid or cystic, painless or painful with different ways for management either by close surveillance or by surgical removal. But the breast cancer required hard work to establish the histological and pathological grade.
Conclusion: to treat the breast cancer properly the cancer should stratify into molecular entities by using hormonal biomarker (ER, PR) and using of oncoprotein HER2 and proliferating index Ki-67, usage of these markers is satisfying for grouping the breast cancer subtypes into four major entities which are Luminal A, Luminal B, HER2+, and triple negative tumor.
Breast; Cancer; Lipoma; Adenoma; Biomarkers
https://gscarr.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCARR-2022-…

Preview Article PDF

Ahmed F. Hameed, Khalida I. Noel and Israa S. Ajeel. Breast lumps: Types, biomarkers and prognosis. GSC Advanced Research and Reviews, 2022, 12(1), 126-134. Article DOI: https://doi.org/10.30574/gscarr.2022.12.1.0199

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 GSC Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution